U.S. Semiconductors Stock News

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

If you are looking at FMC and wondering whether today’s price gives you genuine value or just a value trap, this article will walk through what the numbers actually say about the stock. The share price closed at US$13.67, with returns of a 14.1% decline over the past 7 days, 7.9% decline over 30 days, 4.7% decline year to date, 59.7% decline over 1 year, 88.1% decline over 3 years and 85.5% decline over 5 years. This performance is likely to catch the eye of investors reassessing risk and...

As February 2026 begins, the U.S. stock market has kicked off the month with a strong performance, highlighted by significant gains in major indices such as the Dow Jones Industrial Average and S&P 500. Amidst this positive momentum, small-cap stocks are drawing attention due to their potential for growth and unique opportunities presented by current economic conditions. In this environment, identifying promising investments often involves looking at companies with solid fundamentals and...

CleanSpark (NasdaqCM:CLSK) has secured access to up to 890 megawatts of utility scale power capacity in the Houston area. The company is acquiring additional land at its Sandersville site to support new infrastructure build out. Management has outlined plans to develop a multi gigawatt AI infrastructure platform alongside its existing bitcoin mining operations. For investors watching bitcoin miners, CleanSpark now sits in a different bucket, with a stated ambition to pair high performance...

What recent returns say about Synaptics Synaptics (SYNA) has drawn investor attention after a strong past 3 months, with the stock up about 32% and a 1 year total return near 17%, alongside recent annual revenue growth and improved net income. See our latest analysis for Synaptics. The recent 90 day share price return of about 32% suggests momentum has picked up, even though the 3 year and 5 year total shareholder returns, at around 30% declines, point to a tougher longer term experience...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Sprout Social, Inc. ( NASDAQ:SPT ) shares have had a horrible month, losing 27% after a relatively good period...

As February 2026 begins, U.S. stock markets have shown a strong start with major indices like the Dow Jones and S&P 500 ending sharply higher, reflecting investor optimism despite recent economic uncertainties such as delayed jobs data and trade negotiations. In this context of market volatility and potential opportunities, identifying stocks that may be undervalued by current market estimates could provide investors with promising prospects for growth in their portfolios.

Key Insights Given the large stake in the stock by institutions, COMPASS Pathways' stock price might be vulnerable to...

If you are wondering whether Carlisle Companies at around US$401 per share is still reasonably priced or starting to look stretched, you are not alone. The stock has moved sharply recently, with returns of 17.3% over the past week, 19.3% over the past month, 22.1% year to date, 16.1% over 1 year, 63.4% over 3 years, and 182.8% over 5 years. These moves have kept Carlisle on many investors' watchlists, as the share price action can influence how people think about both risk and opportunity...

The Roadzen, Inc. ( NASDAQ:RDZN ) share price has softened a substantial 34% over the previous 30 days, handing back...

Paylocity Holding Corporation ( NASDAQ:PCTY ) shareholders may have reason to be concerned, as several insiders sold...

GPGI, Inc. previously announced its first-ever quarterly cash dividend of US$0.0025 per Class A share, payable on February 27, 2026, to shareholders of record as of February 13, 2026, representing an annual cash distribution of about US$2.90 million. The move follows a US$2.50 billion refinancing tied to GPGI’s merger with Husky Technologies Limited, highlighting a shift toward regular shareholder payouts alongside debt reduction and acquisition plans. We’ll now examine how GPGI’s inaugural...

H2O America’s board has declared a quarterly cash dividend of US$0.44 per share, payable on March 2, 2026, to shareholders of record on February 9, 2026, representing a 4.8% increase over the December 2025 payout and implying an expected 2026 annualized dividend of US$1.76 per share versus US$1.68 in 2025. This higher dividend and explicit 2026 payout guidance highlight management’s willingness to return more cash to investors and provide clearer income visibility. With the dividend increase...

As the U.S. stock market kicked off February with a strong performance, highlighted by significant gains in major indices like the Dow Jones and S&P 500, investors are keenly observing growth companies that insiders are heavily investing in. In this thriving market environment, companies with high insider ownership often signal confidence from those who know the business best, making them an intriguing focus for those looking to understand where growth potential may lie.

To the annoyance of some shareholders, i3 Verticals, Inc. ( NASDAQ:IIIV ) shares are down a considerable 26% in the...

As February begins, major U.S. stock indexes have surged, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. This optimistic start to the month highlights a market environment where investors are keenly exploring opportunities across various sectors. Though often seen as a relic of past trading days, penny stocks still represent significant growth potential, particularly when they come from smaller or newer companies with strong financial foundations.

We feel now is a pretty good time to analyse Elauwit Connection, Inc.'s ( NASDAQ:ELWT ) business as it appears the...

Kymera Therapeutics (KYMR) has just started dosing patients in its BREADTH Phase 2b trial for KT-621 in moderate to severe eosinophilic asthma, a clinical milestone that is helping shape current sentiment around the stock. See our latest analysis for Kymera Therapeutics. Alongside this new KT-621 asthma trial and the ongoing BROADEN2 study in atopic dermatitis, Kymera Therapeutics’ recent conference appearances and analyst commentary have kept it in focus. The share price is US$75.94, with a...

If you are looking at Paramount Skydance and wondering whether the current share price reflects its true worth, you are not alone. The stock has recently closed at US$10.52, with returns of a 6.2% decline over 7 days, a 15.0% decline over 30 days, a 20.2% decline year to date, and 0.5% over 1 year, while longer periods show a 48.5% decline over 3 years and a 79.7% decline over 5 years. These price moves have come as investors reassess the combined business following the creation of Paramount...

The U.S. stock market has kicked off February with a strong performance, as major indexes like the Dow Jones Industrial Average and S&P 500 have surged, reflecting optimism amid recent economic developments such as trade deals and manufacturing growth. In this dynamic environment, identifying promising stocks often involves looking beyond the usual suspects to uncover lesser-known companies that are poised for growth due to unique positioning or innovative strategies in their respective...

The Broadwind, Inc. ( NASDAQ:BWEN ) share price has softened a substantial 35% over the previous 30 days, handing back...

As February 2026 begins, the U.S. stock market has seen a strong start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. Amid this positive momentum, investors continue to seek reliable income streams, making dividend stocks an attractive option in a landscape marked by economic shifts and policy changes.

Key Insights The considerable ownership by individual investors in SOPHiA GENETICS indicates that they collectively...